Ignite Creation Date:
2024-05-05 @ 12:00 PM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00205777
Status:
COMPLETED
Last Update Posted:
2013-04-10
First Post:
2005-09-16
Brief Title:
Study Evaluating Bazedoxifene Acetate In Osteoporosis In Postmenopausal Women
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
Fracture Incidence Reduction And Safety Of TSE-424 Bazedoxifene Acetate Compared To Placebo And Raloxifene In Osteoporotic Postmenopausal Women
Status:
COMPLETED
Status Verified Date:
2013-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine whether bazedoxifene acetate is safe and effective in the treatment of osteoporosis in postmenopausal women
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| B1781001 | None | None | None |